Medicinálny Tekutý Kyslík Air Products (Oxygen)

When inhaled, oxygen diffuses across the alveolar membrane into the bloodstream, raising arterial oxygen tension. This increased partial pressure enhances the gradient for oxygen transfer into red blood cells, allowing hemoglobin to bind more oxygen and deliver it to tissues, supporting cellular metabolism and energy production.

The prescribed dose of liquid oxygen is determined by the treating clinician based on the patient’s oxygen saturation, underlying condition, and clinical response. Healthcare providers set the flow rate and duration to achieve target oxygen levels while minimizing risk.

There is limited specific data on the safety of supplemental oxygen in pregnancy or lactation. Oxygen therapy is generally considered safe when medically indicated, but the decision should be made by a qualified healthcare professional weighing potential benefits and risks.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Medicinálny Tekutý Kyslík is a liquid form of medical oxygen, offering high purity and compact storage compared with compressed gas cylinders. It can be vaporised on‑site, providing flexibility for large‑volume or remote settings, whereas traditional cylinders require more space and weight for equivalent oxygen content.

Store liquid oxygen cylinders at ambient temperature in a well‑ventilated, dry area away from direct sunlight, heat sources and combustible materials. Keep cylinders upright, secure them to prevent tipping, and ensure proper ventilation to avoid oxygen enrichment of the surrounding air.

The liquid oxygen is vaporised using a regulator and delivered to the patient via approved inhalation devices such as nasal cannulas or face masks. Administration is controlled by the prescriber, who sets the flow rate and duration according to the patient’s oxygen saturation targets.

The most serious risks include pulmonary oxygen toxicity from prolonged high‑concentration exposure, fire hazards due to elevated oxygen levels, and potential damage to equipment if not handled correctly. Patients should be monitored closely for signs of toxicity and all safety precautions must be followed.

Patients with known hypersensitivity to oxygen delivery systems, those with uncontrolled fire‑risk environments (e.g., active smokers), or individuals for whom high‑flow oxygen is contraindicated (such as certain chronic obstructive pulmonary disease patients with CO₂ retention) should not receive this therapy without specialist evaluation.